In addition to CD33 and CD74 [40, 47], other AD genes (ABCA7 and TREM2) are also expressed in microglia [48, 49], suggesting that the modulation of microglial function may be a promising mechanism-based strategy for AD intervention. This evidence concerns the gene ABCA7 and Alzheimer disease.